Published in Lancet on October 06, 1979
Proctalgia fugax, an evidence-based management pathway. Int J Colorectal Dis (2010) 0.85
Functional Anorectal Disorders. Gastroenterology (2016) 0.85
Paroxysmal anal hyperkinesis: a characteristic feature of proctalgia fugax. Gut (1996) 0.83
Hereditary proctalgia fugax and constipation: report of a second family. Gut (1995) 0.83
Oral clonidine for proctalgia fugax. Gut (1987) 0.77
Functional anorectal disorders. Clin Colon Rectal Surg (2005) 0.75
Anorectal and Pelvic Pain. Mayo Clin Proc (2016) 0.75
A simple index of Crohn's-disease activity. Lancet (1980) 11.12
Effects of increased dietary fibre on intestinal transit. Lancet (1973) 3.49
Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome. Lancet (1973) 3.18
Organic and functional disorders in 2000 gastroenterology outpatients. Lancet (1983) 2.78
Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet (1987) 2.13
The effect of wheat bran on intestinal transit. Gut (1975) 2.10
Measurement of gastric emptying time with a gamma camera. Lancet (1970) 2.08
Indices of thyroid function in thyrotoxicosis. Lancet (1971) 1.83
Wheat fibre and irritable bowel syndrome. A controlled trial. Lancet (1977) 1.80
The late results of medical and surgical treatment for bleeding duodenal ulcer. Q J Med (1970) 1.70
Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther (2011) 1.59
Multifocal gastric carcinoid tumours, achlorhydria, and hypergastrinaemia. Lancet (1985) 1.48
A radioimmunoassay for cholecystokinin-pancreozymin. Lancet (1973) 1.33
Saline purgatives act by releasing cholecystokinin. Lancet (1973) 1.15
Preparation of prereduced anaerobically sterilized media and their use in cultivation of anaerobic bacteria. J Clin Microbiol (1978) 1.13
Changes in certain blood constituents during Ramadan. Am J Clin Nutr (1982) 1.09
Measuring Crohn's disease activity. Lancet (1980) 1.09
Radioimmunoassay of cholecystokinin-pancreozymin. Gut (1974) 1.06
Applying psychometric criteria to functional assessment in medical rehabilitation: II. Defining interval measures. Arch Phys Med Rehabil (1992) 1.05
Intracellular messenger role of cyclic GMP in exocrine pancreas. Nature (1976) 1.05
Breakfast and Crohn's disease--II. Br Med J (1978) 1.03
Improving the diagnosis of coeliac disease in anaemic women. Br J Haematol (2000) 1.03
Applying psychometric criteria to functional assessment in medical rehabilitation: I. Exploring unidimensionality. Arch Phys Med Rehabil (1991) 1.01
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. Aliment Pharmacol Ther (2003) 0.99
Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. Gut (1990) 0.96
Psychiatric disorders in patients with spinal cord injuries. Arch Gen Psychiatry (1981) 0.96
Effects of cholecystokinin on colonic motility and symptoms in patients with the irritable bowel syndrome. Gut (1972) 0.95
Radioimmunoassay of lactoferrin in pancreatic juice as a test for pancreatic diseases. Lancet (1978) 0.94
Functional performance assessment: a program approach. Arch Phys Med Rehabil (1981) 0.93
Relationship between changes in plasma gastrin and lower oesophageal sphincter pressure after meals. Br J Surg (1975) 0.92
Spontaneous resolution of multifocal gastric enterochromaffin-like cell carcinoid tumours. Lancet (1988) 0.90
Iron-deficiency anaemia in premenopausal women. Lancet (1999) 0.90
Abnormalities of serum cholecystokinin and gallbladder emptying in celiac disease. N Engl J Med (1975) 0.89
Proceedings: Studies on the nature of cholecystokininpancreozymin in small-intestinal mucosal extracts. Gut (1974) 0.88
Chondroitin sulfatase--producing and hyaluronidase--producing oral bacteria associated with periodontal disease. J Can Dent Assoc (1982) 0.88
Rehabits: a common language of functional assessment. Arch Phys Med Rehabil (1995) 0.87
Bowel habit in thyrotoxicosis and hypothyroidism. Br Med J (1971) 0.87
Functional abilities and distress levels in brain injured patients at long-term follow-up. Arch Phys Med Rehabil (1982) 0.86
Risk factors for death and emergency transfer in acute and subacute inpatient rehabilitation. Arch Phys Med Rehabil (1996) 0.85
Use of fluorescence microscopy for monitoring periodontal disease state. Can J Microbiol (1981) 0.85
Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet (1977) 0.85
Dreaming during scientific papers: effects of added extrinsic material. Br Med J (Clin Res Ed) (1984) 0.85
Hormonal content and effect on gallbladder of commercial preparations of cholecystokinin-pancreozymin. Horm Metab Res (1981) 0.84
Oxygen saturation during sleep in patients with spinal cord injury. Am J Phys Med (1982) 0.84
Effects of oral magnesium sulphate on colonic motility in patients with the irritable bowel syndrome. Gut (1973) 0.83
Trypsin and lactoferrin levels in pure pancreatic juice in patients with pancreatic disease. Gut (1979) 0.83
Abdominal and thoracic pressures during defaecation. Br Med J (1979) 0.83
The diagnosis of intra-abdominal abscesses in patients with severe Crohn's disease. Q J Med (1992) 0.82
Cannabis effect on spasticity in spinal cord injury. Arch Phys Med Rehabil (1982) 0.82
Relationship between changes of serum cholecystokinin-pancreozymin and serum insulin after different stimuli. Diabetologia (1975) 0.81
Serum-thyroxine and thyroxine-binding globulin in seriously ill patients. Lancet (1971) 0.81
Drugs and thyroid-function tests. Br Med J (1967) 0.81
Hormonal control of gastrointestinal motility. Am J Dig Dis (1975) 0.80
Depression in spinal cord injured patients. Paraplegia (1981) 0.80
Effect of metiamide on basal and stimulated serum cholecystokinin levels in duodenal ulcer patients. Gut (1976) 0.80
Thyroxine "addicts". Br Med J (1973) 0.80
Dyshormonogenetic goitre with high circulating levels of thyroid-stimulating hormone. Proc R Soc Med (1971) 0.80
Bacteroides species and gelatinase-producers in periodontal disease. J Can Dent Assoc (1982) 0.79
Accidental hypothermia in erythroderma from generalized psoriasis. Arch Dermatol (1968) 0.79
The irritable bowel syndrome. Part III: hormonal influences. Clin Gastroenterol (1977) 0.79
Computerized tomography head scans as predictors of functional outcome of stroke patients. Arch Phys Med Rehabil (1988) 0.79
Serum trypsin as measure of pancreatic exocrine function in children with protein calorie malnutrition. Lancet (1980) 0.78
Vocational/educational services in a medical rehabilitation facility: outcomes in spinal cord and brain injured patients. Arch Phys Med Rehabil (1982) 0.78
Effects of oral magnesium sulphate on colonic motility. Gut (1973) 0.77
Cancer rehabilitation. An analysis of 36 program approaches. JAMA (1982) 0.77
Pathogenesis of the impaired gall bladder contraction of coeliac disease. Gut (1987) 0.76
Effect of coffee on human lower oesophageal function. Digestion (1981) 0.76
The effect of substance P on cyclic AMP and cyclic GMP levels in actively secreting pancreatic lobules [proceedings]. J Physiol (1978) 0.76
Crohn's disease presenting as recurrent pulmonary oedema. Br Med J (Clin Res Ed) (1981) 0.75
Gastric ECL cell hyperplasia. Gut (1987) 0.75
The knee-elbow position relieves distension. Gut (1994) 0.75
Gut peptides and the control of food intake. Br Med J (Clin Res Ed) (1983) 0.75
Colonoscopy first for iron-deficiency anaemia. QJM (2007) 0.75
Grades of hypothyroidism. Br Med J (1973) 0.75
Periodontics. Mcgill Dent Rev (1971) 0.75
Antidiarrhoeal agents. Clinical pharmacology and therapeutic use. Drugs (1982) 0.75
Gallbladder emptying in celiac disease. Gastroenterology (1986) 0.75
The use of 131I labelled human serum albumin in the assessment of improved lymph flow following buried dermis flap operation in cases of post-mastectomy lymphoedema of the arm. Br J Radiol (1969) 0.75
Rehabilitation team and family assessment of the initial home pass. Arch Phys Med Rehabil (1986) 0.75
Single appointment therapy for a periodontal abscess. Dent J (1974) 0.75
Letter: Assays for cholecystokinin-pancreozymin. Lancet (1973) 0.75
Catecholamine metabolites in spinal cord injury. Arch Phys Med Rehabil (1982) 0.75
Regulation of the serum free thyroxine fraction by thyroxine-binding globulin. J Endocrinol (1969) 0.75
Purchasing research from or for the NHS. J R Coll Physicians Lond (1995) 0.75
Secretin and prosecretin. Lancet (1973) 0.75
Investigation of the normal TBG levels found in thyroid disease. Clin Sci (1970) 0.75
Proceedings: A radioimmunoassay for cholecystokinin-pancreozymin. Gut (1973) 0.75
Computerized tomography head scans as predictors of rehabilitation outcome. Arch Phys Med Rehabil (1984) 0.75
Letter: Gastric hypersecretion and pancreatic exocrine deficiency. Arch Surg (1974) 0.75
Transition or change? J Outcome Meas (2000) 0.75
Single-contrast small bowel enteroclysis: the province of the radiographer? Clin Radiol (2004) 0.75
Chronic pancreatitis in Bristol. Bristol Med Chir J (1983) 0.75
Serum trypsin in hepatosplenic schistosomiasis in the Sudan. Trop Med Parasitol (1990) 0.75
Direct comparison of a small gamma camera with a rectilinear scanner for thyroid scintigraphy. Clin Radiol (1970) 0.75
99Tcm-nanocolloid imaging in inflammatory bowel disease. Nucl Med Commun (1990) 0.75
Investigation of ureteric function by isotope renography: with particular reference to patients with "unexplained" renal pain. Lancet (1969) 0.75
Lactoferrin concentration in the parotid saliva of patients with chronic pancreatitis. Digestion (1983) 0.75
Patient profiles: utilization in functional performance assessment. Arch Phys Med Rehabil (1983) 0.75
Computerized data bases: an integrated approach to monitoring quality of patient care. Arch Phys Med Rehabil (1987) 0.75
Changes in thyroxine-binding globulin levels in thyrotoxicosis and in healthy subjects after triiodothyronine administration. Acta Endocrinol (Copenh) (1970) 0.75